Australian drugs regulator cancels registration of COX 2 inhibitor

BMJ. 2007 Aug 25;335(7616):363. doi: 10.1136/bmj.39311.635822.DB.
No abstract available

Publication types

  • News

MeSH terms

  • Australia
  • Cyclooxygenase 2 Inhibitors / adverse effects
  • Cyclooxygenase 2 Inhibitors / supply & distribution*
  • Diclofenac / adverse effects
  • Diclofenac / analogs & derivatives*
  • Diclofenac / supply & distribution
  • Drug Approval
  • Humans
  • Osteoarthritis / drug therapy*

Substances

  • Cyclooxygenase 2 Inhibitors
  • Diclofenac
  • lumiracoxib